Meeting
2023 ASCO Gastrointestinal Cancers Symposium
Effect of CXCL1 on the NF-κB/P300 signaling pathway and colon cancer progression.
Authors
Changhua Zhuo
Department of Gastrointestinal Surgical Oncology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, China;
Changhua Zhuo , Qiang Ruan , Xiangqian Zhao , Yangkun Shen , Ruirong Lin
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 41, 2023 (suppl 4; abstr 236)
DOI
10.1200/JCO.2023.41.4_suppl.236
Abstract #
236
Poster Bd #
M18
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Breakthrough
Investigation of a tamoxifen-RACK7/KDM5C-IFN-I axis for ER+ breast cancer immunomodulation.
First Author: Marvin Angelo Esteban Aberin
First Author: Kimberly Stephanie Meza
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Results from a phase 2 study of triplet blockade of the IL-27, PD-(L)1, and VEGF pathways with casdozokitug (casdozo, SRF388) in combination with atezolizumab (atezo) and bevacizumab (bev) in patients with unresectable, locally advanced, or metastatic hepatocellular carcinoma (uHCC).
First Author: Daneng Li
Poster
2023 ASCO Annual Meeting
Impact of vitamin d on the colon tumor immune microenvironment: Results of a randomized clinical trial of preoperative vitamin D supplementation in patients with stage I-III colon cancer.
First Author: Andressa Dias Costa